Verapamil and risk of cancer in patients with coronary artery disease
- 1 May 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (9) , 1419-1422
- https://doi.org/10.1016/s0002-9149(99)00113-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Calcium Channel Blockers and the Risk of CancerJAMA, 1998
- Use of calcium channel blockers and breast carcinoma risk in postmenopausal womenCancer, 1997
- Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.American Journal of Hypertension, 1997
- Cancer Risk in Users of Calcium Channel BlockersHypertension, 1997
- Calcium-channel blockers and risk of cancerThe Lancet, 1997
- Calcium-channel blockade and incidence of cancer in aged populationsThe Lancet, 1996
- Apoptosis and diseaseThe Lancet, 1993
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis.Proceedings of the National Academy of Sciences, 1988
- THE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIESAnnals of Human Genetics, 1956